DYRK1A and Alzheimer disease: In AD, astrocytic DYRK1A overdosage (Altafaj et al., 2001; Ferrer et al., 2005) could potentially dysregulate the Aβ production/degradation balance in astrocytes by promoting Aβ synthesis as well as reducing its degradation (Figure 3I).